Abstract:Acinetobacter baumannii is an opportunistic pathogen with ability to cause serious infection such as bacteremia, ventilator associated pneumonia, and wound infections. As strains of A. baumannii are resistant to almost all clinically used antibiotics and with the emergence of carbapenems resistant phenotypes warrants the search for novel antibiotics. Considering this, herein, a series of computer aided drug designing approach was utilized to search novel chemical scaffolds that bind stronger to MurE ligase enzyme of A. baumannii, which is involved peptidoglycan synthesis. The work identified LAS_22461675, LAS_34000090 and LAS_51177972 compounds as promising binding molecules with MurE enzyme having binding energy score of -10.5 kcal/mol, -9.3 kcal/mol and -8.6 kcal/mol, respectively. The compounds were found to achieve docked inside the MurE substrate binding pocket and established close distance chemical interactions. The interaction energies were dominated by van der Waals and less contributions were seen from hydrogen bonding energy. The dynamic simulation assay predicted the complexes stable with no major global and local changes noticed. The docked stability was also validated by MM/PBSA and MM/GBSA binding free energy methods. The net MM/GBSA binding free energy of LAS_22461675 complex, LAS_34000090 complex and LAS_51177972 complex is -26.25 kcal/mol, -27.23 kcal/mol and -29.64 kcal/mol, respectively. Similarly in case of MM-PBSA, the net energy value was in following order; LAS_22461675 complex (-27.67 kcal/mol), LAS_34000090 complex (-29.94 kcal/mol) and LAS_51177972 complex (-27.32 kcal/mol). The AMBER entropy and WaterSwap methods also confirmed stable complexes formation. Further, molecular features of the compounds were determined that predicted compounds to have good druglike properties and pharmacokinetic favorable. The study concluded the compounds to good candidates to be tested by in vivo and in vitro experimental assays.Communicated by Ramaswamy H. Sarma.

Identification through structure-based methods of a bacterial NAD(+)-dependent DNA ligase inhibitor that avoids known resistance mutations(vol 24, pg 360, 2014)

Identification Through Structure-Based Methods of a Bacterial NAD(+)-dependent DNA Ligase Inhibitor That Avoids Known Resistance Mutations.

Novel Bacterial NAD + -Dependent DNA Ligase Inhibitors with Broad-Spectrum Activity and Antibacterial Efficacy in Vivo

Structure guided understanding of NAD+ recognition in bacterial DNA ligases.

Identification of promising anti-DNA gyrase antibacterial compounds using de novo design, molecular docking and molecular dynamics studies

Pyrrolamide DNA gyrase inhibitors: fragment-based nuclear magnetic resonance screening to identify antibacterial agents.

Novel and Structurally Diversified Bacterial DNA Gyrase Inhibitors Discovered through a Fluorescence-Based High-Throughput Screening Assay

In silico evaluation of usnic acid derivatives to discover potential antibacterial drugs against DNA gyrase B and DNA topoisomerase IV

Identification of Small Molecule Inhibitors of RNase L by Fragment-Based Drug Discovery.

Identification of 6-Anilino Imidazo[4,5- c]pyridin-2-ones as Selective DNA-Dependent Protein Kinase Inhibitors and Their Application as Radiosensitizers

Identification of small molecules that are synthetically lethal upon knockout of the RNA ligase Rlig1 in human cells

Identification of small-molecule inhibitors of human MUS81-EME1/2 by FRET-based high-throughput screening

Unveiling MurE ligase potential inhibitors for treating multi-drug resistant Acinetobacter baumannii

Exploring the Ligandability of 53BP1 Through Fragment-Based Approaches

Fragment-Based Discovery of Novel MUS81 Inhibitors

A role for the ATP-dependent DNA ligase lig E of Neisseria gonorrhoeae in biofilm formation

Pyranonaphthoquinone Lactones: a New Class of AKT Selective Kinase Inhibitors Alkylate a Regulatory Loop Cysteine.

Selective Inhibitors of Bacterial T-Rna-(n(1)g37) Methyltransferase (trmd) That Demonstrate Novel Ordering of the Lid Domain.

Ligand-Based Virtual Screening for Discovery of Indole Derivatives as Potent DNA Gyrase ATPase Inhibitors Active against Mycobacterium tuberculosis and Hit Validation by Biological Assays

Discovery of novel bacterial topoisomerase I inhibitors by use of in silico docking and in vitro assays

Thermodynamical Properties of Protein Kinase with Adenine Inhibitors